Center-Authored Papers

Filters: Author is Tsao, Anne S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
O
Ou S-HI, Moon J, Garland LL, Mack PC, Testa JR, Tsao AS, Wozniak AJ, Gandara DR.  2015.  SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(2):387-91. Abstract
T
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan UA, McWilliams A, Tsao MS et al..  2016.  Scientific Advances in Lung Cancer 2015.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
Tsao AS, Garland L, Redman MW, Kernstine K, Gandara D, Marom EM.  2011.  Reply to the Letter to the Editor Entitled A Practical Guide to Measure "All" Malignant Pleural Mesothelioma Tumors by Modified RECIST Criteria? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(12):2144-5.